Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 6/2008

01-08-2008 | Original Paper

Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease

Authors: Steffen Bohl, Ralf Wassmuth, Hassan Abdel-Aty, André Rudolph, Daniel Messroghli, Rainer Dietz, Jeanette Schulz-Menger

Published in: The International Journal of Cardiovascular Imaging | Issue 6/2008

Login to get access

Abstract

Background Late gadolinium-hyperenhancement (LHE) on cardiac Magnetic Resonance Imaging (CMR) has been linked to cardiovascular risk in ischemic and non-ischemic heart disease. We aimed to systematically categorize LHE-patterns in a variety of non-ischemic heart diseases (NIHD) and to explore their relationship with left ventricular (LV) function. Methods In a retrospective database search, 156 patients with NIHD who exhibited LHE on CMR were identified. All images were re-analyzed stepwise. LHE was correlated to LV functional parameters. Cardiac magnetic resonance (CMR) was conducted on 1.5 T scanners. Results Typically, LHE spared the subendocardium. Consistent LHE-patterns were observed in myocarditis, hypertrophic and dilated cardiomyopathy and systemic vasculitis. No conclusive LHE-patterns were observed in patients with aortic stenosis, arterial hypertension, lupus erythematosus, sarcoidosis, ventricular arrhythmia and in a mixed subgroup of rare NIHDs. There was no significant relationship between LHE and ejection fraction. There was no correlation between enddiastolic volume and LHE in either myocarditis (P = 0.13) or dilated cardiomyopathy (P = 0.62). LHE was unrelated to LV-mass in aortic stenosis (P = 0.13) and hypertrophic cardiomyopathy (P = 0.38). Conclusions Distinct LHE patterns exist in various NIHDs and their visualization may ultimately aid diagnosis. Unlike in ischemic heart disease, the structure-function relationship does not appear to be strong.
Literature
1.
go back to reference Wagner A, Mahrholdt H, Holly TA et al (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361:374–379CrossRefPubMed Wagner A, Mahrholdt H, Holly TA et al (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361:374–379CrossRefPubMed
2.
go back to reference Bello D, Fieno DS, Kim RJ et al (2005) Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45:1104–1108CrossRefPubMed Bello D, Fieno DS, Kim RJ et al (2005) Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45:1104–1108CrossRefPubMed
3.
go back to reference Abdel-Aty H, Boye P, Zagrosek A et al (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45:1815–1822CrossRefPubMed Abdel-Aty H, Boye P, Zagrosek A et al (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45:1815–1822CrossRefPubMed
4.
go back to reference Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156–2164CrossRefPubMed Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156–2164CrossRefPubMed
5.
go back to reference McCrohon JA, Moon JC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59CrossRefPubMed McCrohon JA, Moon JC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59CrossRefPubMed
6.
go back to reference Mahrholdt H, Goedecke C, Wagner A et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109:1250–1258CrossRefPubMed Mahrholdt H, Goedecke C, Wagner A et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109:1250–1258CrossRefPubMed
7.
go back to reference Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985CrossRefPubMed Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985CrossRefPubMed
8.
go back to reference Nazarian S, Bluemke DA, Lardo AC et al (2005) Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112:2821–2825CrossRefPubMed Nazarian S, Bluemke DA, Lardo AC et al (2005) Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112:2821–2825CrossRefPubMed
9.
go back to reference Gottlieb I, Macedo R, Bluemke DA, Lima JA (2006) Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives. Heart Fail Rev 11:313–323CrossRefPubMed Gottlieb I, Macedo R, Bluemke DA, Lima JA (2006) Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives. Heart Fail Rev 11:313–323CrossRefPubMed
10.
go back to reference Jackson E, Bellenger N, Seddon M et al (2007) Ischaemic and non-ischaemic cardiomyopathies-cardiac MRI appearances with delayed enhancement. Clin Radiol 62:395–403CrossRefPubMed Jackson E, Bellenger N, Seddon M et al (2007) Ischaemic and non-ischaemic cardiomyopathies-cardiac MRI appearances with delayed enhancement. Clin Radiol 62:395–403CrossRefPubMed
11.
go back to reference Vogel-Claussen J, Rochitte CE, Wu KC et al (2006) Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics 26:795–810CrossRefPubMed Vogel-Claussen J, Rochitte CE, Wu KC et al (2006) Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics 26:795–810CrossRefPubMed
12.
go back to reference Mahrholdt H, Wagner A, Judd RM et al (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474CrossRefPubMed Mahrholdt H, Wagner A, Judd RM et al (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474CrossRefPubMed
13.
go back to reference Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 93:841–842PubMed Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 93:841–842PubMed
14.
go back to reference Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542CrossRefPubMed Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542CrossRefPubMed
15.
go back to reference Carr DH, Brown J, Bydder GM et al (1984) Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. AJR Am J Roentgenol 143:215–224PubMed Carr DH, Brown J, Bydder GM et al (1984) Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. AJR Am J Roentgenol 143:215–224PubMed
16.
go back to reference Kim RJ, Chen EL, Lima JA, Judd RM (1996) Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94:3318–3326PubMed Kim RJ, Chen EL, Lima JA, Judd RM (1996) Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94:3318–3326PubMed
17.
go back to reference Aso H, Takeda K, Ito T et al (1998) Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol 33:22–32CrossRefPubMed Aso H, Takeda K, Ito T et al (1998) Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol 33:22–32CrossRefPubMed
18.
go back to reference Messroghli DR, Radjenovic A, Kozerke S et al (2004) Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52:141–146CrossRefPubMed Messroghli DR, Radjenovic A, Kozerke S et al (2004) Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52:141–146CrossRefPubMed
19.
go back to reference Mahrholdt H, Wagner A, Deluigi CC et al (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–1590CrossRefPubMed Mahrholdt H, Wagner A, Deluigi CC et al (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–1590CrossRefPubMed
20.
go back to reference Lenghaus C, Studdert MJ (1984) Acute and chronic viral myocarditis. Acute diffuse nonsuppurative myocarditis and residual myocardial scarring following infection with canine parvovirus. Am J Pathol 115:316–319PubMed Lenghaus C, Studdert MJ (1984) Acute and chronic viral myocarditis. Acute diffuse nonsuppurative myocarditis and residual myocardial scarring following infection with canine parvovirus. Am J Pathol 115:316–319PubMed
21.
go back to reference Bultmann BD, Klingel K, Sotlar K et al (2003) Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34:92–95CrossRefPubMed Bultmann BD, Klingel K, Sotlar K et al (2003) Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34:92–95CrossRefPubMed
22.
go back to reference Magnani JW, Danik HJ, Dec GW Jr, DiSalvo TG (2006) Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J 151:463–470CrossRefPubMed Magnani JW, Danik HJ, Dec GW Jr, DiSalvo TG (2006) Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J 151:463–470CrossRefPubMed
23.
go back to reference McCarthy RE III, Boehmer JP, Hruban RH et al (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690–695CrossRefPubMed McCarthy RE III, Boehmer JP, Hruban RH et al (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690–695CrossRefPubMed
24.
go back to reference Cooper LT Jr, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis-natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 336:1860–1866CrossRefPubMed Cooper LT Jr, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis-natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 336:1860–1866CrossRefPubMed
25.
go back to reference Knaapen P, van Dockum WG, Bondarenko O et al (2005) Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. J Nucl Med 46:923–929PubMed Knaapen P, van Dockum WG, Bondarenko O et al (2005) Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. J Nucl Med 46:923–929PubMed
26.
go back to reference Moon JC, Mogensen J, Elliott PM et al (2005) Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart 91:1036–1040CrossRefPubMed Moon JC, Mogensen J, Elliott PM et al (2005) Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart 91:1036–1040CrossRefPubMed
27.
go back to reference Debl K, Djavidani B, Buchner S et al (2006) Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart 92:1447–1451CrossRefPubMed Debl K, Djavidani B, Buchner S et al (2006) Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart 92:1447–1451CrossRefPubMed
28.
go back to reference Blyth KG, Groenning BA, Martin TN et al (2005) Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 26:1993–1999CrossRefPubMed Blyth KG, Groenning BA, Martin TN et al (2005) Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 26:1993–1999CrossRefPubMed
29.
go back to reference Kuribayashi T, Roberts WC (1992) Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 70:1333–1340CrossRefPubMed Kuribayashi T, Roberts WC (1992) Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 70:1333–1340CrossRefPubMed
30.
go back to reference Maehashi N, Yokota Y, Takarada A et al (1991) The role of myocarditis and myocardial fibrosis in dilated cardiomyopathy. Analysis of 28 necropsy cases. Jpn Heart J 32:1–15PubMed Maehashi N, Yokota Y, Takarada A et al (1991) The role of myocarditis and myocardial fibrosis in dilated cardiomyopathy. Analysis of 28 necropsy cases. Jpn Heart J 32:1–15PubMed
31.
go back to reference Roberts WC, Siegel RJ, McManus BM (1987) Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60:1340–1355CrossRefPubMed Roberts WC, Siegel RJ, McManus BM (1987) Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60:1340–1355CrossRefPubMed
32.
go back to reference Pauschinger M, Knopf D, Petschauer S et al (1999) Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 99:2750–2756PubMed Pauschinger M, Knopf D, Petschauer S et al (1999) Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 99:2750–2756PubMed
33.
go back to reference Kawai S, Okada R (1990) Interstitial cell infiltrate and myocardial fibrosis in dilated cardiomyopathy: a special type of cardiomegaly corresponding to sequelae of myocarditis. Heart Vessels 5:230–236CrossRefPubMed Kawai S, Okada R (1990) Interstitial cell infiltrate and myocardial fibrosis in dilated cardiomyopathy: a special type of cardiomegaly corresponding to sequelae of myocarditis. Heart Vessels 5:230–236CrossRefPubMed
34.
go back to reference Cothran LHE, Sandler H (1973) An analysis of left ventricular dimensional changes in conscious animals. Dewy Publication, Washington DC, pp 553–565 Cothran LHE, Sandler H (1973) An analysis of left ventricular dimensional changes in conscious animals. Dewy Publication, Washington DC, pp 553–565
35.
go back to reference Petersen SE, Kardos A, Neubauer S (2005) Subendocardial and papillary muscle involvement in a patient with Churg–Strauss syndrome, detected by contrast enhanced cardiovascular magnetic resonance. Heart 91:e9CrossRefPubMed Petersen SE, Kardos A, Neubauer S (2005) Subendocardial and papillary muscle involvement in a patient with Churg–Strauss syndrome, detected by contrast enhanced cardiovascular magnetic resonance. Heart 91:e9CrossRefPubMed
36.
go back to reference Mukherjee B, Chir B, Moon JC et al (2004) Endomyocardial fibrosis in Churg–Strauss syndrome. Clin Cardiol 27:21CrossRefPubMed Mukherjee B, Chir B, Moon JC et al (2004) Endomyocardial fibrosis in Churg–Strauss syndrome. Clin Cardiol 27:21CrossRefPubMed
37.
go back to reference Hein S, Arnon E, Kostin S et al (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107:984–991CrossRefPubMed Hein S, Arnon E, Kostin S et al (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107:984–991CrossRefPubMed
38.
go back to reference Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 128:1629–1637CrossRefPubMed Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 128:1629–1637CrossRefPubMed
39.
go back to reference Knockaert DC (2007) Cardiac involvement in systemic inflammatory diseases. Eur Heart J 15:1797–1804CrossRef Knockaert DC (2007) Cardiac involvement in systemic inflammatory diseases. Eur Heart J 15:1797–1804CrossRef
Metadata
Title
Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease
Authors
Steffen Bohl
Ralf Wassmuth
Hassan Abdel-Aty
André Rudolph
Daniel Messroghli
Rainer Dietz
Jeanette Schulz-Menger
Publication date
01-08-2008
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 6/2008
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-008-9300-x

Other articles of this Issue 6/2008

The International Journal of Cardiovascular Imaging 6/2008 Go to the issue